Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Pathophysiol Haemost Thromb ; 37(1): 43-8, 2010.
Article in English | MEDLINE | ID: mdl-20516672

ABSTRACT

Measurements of platelet reactivity and assessment of the efficacy of antiplatelet drugs are widely recognized as pre-requisite for the diagnosis and treatment of stroke patients. A recently established shear-induced platelet reactivity test using non-anticoagulated blood (the Global Thrombosis Test) has facilitated measurements of physiologically relevant platelet function and thrombolytic activity. 195 healthy volunteers, not taking antiplatelet drugs or anticoagulants, and 185 patients with acute cerebrovascular diseases were enrolled. The effect of antiplatelet drugs on platelet function and thrombolytic activity was assessed using the Global Thrombosis Test after 14 days of medication. The occlusion time (OT), an index of platelet reactivity, in healthy controls was 284.9 ± 92.2 s. The lysis time (LT), an index of thrombolytic activity, in healthy controls was 2,231 ± 1,223 s. Both times had no significant difference between males and females. The OT of all stroke patients was 210.3 ± 140.8 s and was shorter than that of the healthy controls (284.9 ± 92.2, p < 0.0001). The LT of all stroke patients was 3,159 ± 1,549 s and was longer than that of the controls (2,231 ± 1,223, p < 0.0001). Medication significantly prolonged the OT from 184.5 ± 150.6 s (before) to 295.3 ± 208.1 s (after) in all patients, indicating a reversal of the hyper-platelet reactivity. In addition, medication shortened the LT from 3,924 ± 1,718 s (before) to 3,107 ± 1,794 s (after) in all patients. A prothrombotic state exists in stroke patients due to enhanced platelet function and suppressed thrombolytic activity. Medication improved these physiological parameters of haemostasis.


Subject(s)
Blood Platelets/physiology , Cerebral Infarction/blood , Platelet Aggregation/physiology , Platelet Function Tests/methods , Stroke/blood , Adult , Aged , Anticoagulants/therapeutic use , Aspirin/therapeutic use , Blood Coagulation/physiology , Blood Platelets/drug effects , Cerebral Infarction/drug therapy , Female , Fibrinolytic Agents/therapeutic use , Humans , Male , Methacrylates/therapeutic use , Middle Aged , Platelet Aggregation/drug effects , Platelet Aggregation Inhibitors/therapeutic use , Stroke/drug therapy , Young Adult
2.
Blood Coagul Fibrinolysis ; 22(6): 526-31, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21577091

ABSTRACT

Prevention of arterial thrombotic diseases has a high priority in developed countries. An inappropriate diet is known to enhance the risks for acute thrombotic events, and nutritional products experimentally shown to be antithrombotic, might contribute beneficial effects. The present study forms part of a series of investigations into the antithrombotic effect of various foods and vegetables. Roasted and crushed whole grains from six varieties of sesame seeds were added to the diet of mice. Antithrombotic activity was measured in the carotid artery in vivo, using a He-Ne laser-induced thrombosis technique after 12 weeks. Col/Chichibu/Maruteru-2/1995 and T016 varieties showed significant antithrombotic activity, whilst 00037803 was prothrombotic. The acute effects of purified ingredients, sesamin, sesamolin and sesamol, given orally or intra-arterially, were also examined after a single dose. The most effective ingredient was sesamol, followed by sesamolin and sesamin. Daily intake of specific antithrombotic sesame whole grains or purified active ingredients might help to prevent atherothrombotic diseases.


Subject(s)
Plant Extracts/pharmacology , Sesamum/chemistry , Thrombosis/drug therapy , Thrombosis/prevention & control , Administration, Oral , Animals , Benzodioxoles/pharmacology , Diet, High-Fat , Dioxoles/pharmacology , Disease Models, Animal , Edible Grain/chemistry , Fibrinolytic Agents/chemistry , Fibrinolytic Agents/pharmacology , Fibrinolytic Agents/therapeutic use , Humans , Infusions, Intra-Arterial , Lasers , Lignans/pharmacology , Male , Mice , Mice, Inbred C57BL , Phenols/pharmacology , Plant Extracts/chemistry , Plant Extracts/therapeutic use , Thrombosis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL